Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Us patent 9 107 900 dronedarone?What is pivotal clinical trials and are they applicable for biosimilar?Panitumumab patent expire?Dronedarone generic launch date us?When does ruxolitinib lose patent?
See the DrugPatentWatch profile for cymbalta
Cymbalta (duloxetine) was first approved by the U.S. Food and Drug Administration (FDA) and launched on the market in 2004.
Cymbalta’s market entry in 2004 aligns with its FDA approval year; drug sales typically begin soon after approval once labeling, distribution, and prescribing are set.
Yes. “Going on the market” can vary by country because approval timing differs across regulators. If you tell me the country (U.S., UK, Canada, EU, etc.), I can narrow to that specific launch/approval timeline.
Other Questions About Cymbalta :